Acorai, founded by a seasoned team of innovators, has created a first-of-its[1]kind non-invasive Intracardiac Pressure Monitor
▪ It matters because it is the only way to safely, accurately and cost[1]efficiently manage heart failure patients to improve quality of care
▪ Heart Failure affects more than 60 million people and costs >€300Bn globally
▪ Hospitals will buy our clinically validated solution without the need for
reimbursement as it reduces readmissions, complications and length of stay
▪ Acorai targets an initial global market size exceeding €9bn
▪ Six patent families protect Acorai’s SAVE sensor technology system